Fisher Asset Management LLC Sells 54,715 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fisher Asset Management LLC reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 14.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 312,703 shares of the company’s stock after selling 54,715 shares during the quarter. Fisher Asset Management LLC owned 0.63% of Prestige Consumer Healthcare worth $19,144,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. GAMMA Investing LLC acquired a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at about $25,000. Provence Wealth Management Group acquired a new position in Prestige Consumer Healthcare during the third quarter worth $26,000. Pacer Advisors Inc. grew its position in Prestige Consumer Healthcare by 85.7% in the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after purchasing an additional 204 shares in the last quarter. ORG Partners LLC acquired a new stake in Prestige Consumer Healthcare in the 4th quarter valued at $36,000. Finally, International Assets Investment Management LLC lifted its position in Prestige Consumer Healthcare by 1,900.0% during the 4th quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock worth $60,000 after buying an additional 931 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock opened at $70.00 on Monday. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. The stock has a 50-day simple moving average of $71.12 and a 200 day simple moving average of $64.66. Prestige Consumer Healthcare Inc. has a 52 week low of $55.96 and a 52 week high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.02. The business had revenue of $282.74 million during the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The company’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.04 EPS. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on PBH. TheStreet raised Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. One research analyst has rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and an average target price of $110.00.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total transaction of $368,184.00. Following the transaction, the senior vice president now owns 15,934 shares in the company, valued at approximately $1,099,446. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is currently owned by insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.